Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP500227.RAFWQb6KDbVC_yhPgcumMHbCL6__YH-Y3GLl7WVxDAqc8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP500227.RAFWQb6KDbVC_yhPgcumMHbCL6__YH-Y3GLl7WVxDAqc8130_assertion type Assertion NP500227.RAFWQb6KDbVC_yhPgcumMHbCL6__YH-Y3GLl7WVxDAqc8130_head.
- NP500227.RAFWQb6KDbVC_yhPgcumMHbCL6__YH-Y3GLl7WVxDAqc8130_assertion description "[However, the two main pathways activated by IL-7, JAK/STAT5 and PI3K/Akt/mTOR, have both been implicated in cancer and there is considerable evidence that IL-7 and its receptor (IL-7R), formed by IL-7R? (encoded by IL7R) and ?c, may partake in T-cell acute lymphoblastic leukemia (T-ALL) development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500227.RAFWQb6KDbVC_yhPgcumMHbCL6__YH-Y3GLl7WVxDAqc8130_provenance.
- NP500227.RAFWQb6KDbVC_yhPgcumMHbCL6__YH-Y3GLl7WVxDAqc8130_assertion evidence source_evidence_literature NP500227.RAFWQb6KDbVC_yhPgcumMHbCL6__YH-Y3GLl7WVxDAqc8130_provenance.
- NP500227.RAFWQb6KDbVC_yhPgcumMHbCL6__YH-Y3GLl7WVxDAqc8130_assertion SIO_000772 23234870 NP500227.RAFWQb6KDbVC_yhPgcumMHbCL6__YH-Y3GLl7WVxDAqc8130_provenance.
- NP500227.RAFWQb6KDbVC_yhPgcumMHbCL6__YH-Y3GLl7WVxDAqc8130_assertion wasDerivedFrom befree-20150227 NP500227.RAFWQb6KDbVC_yhPgcumMHbCL6__YH-Y3GLl7WVxDAqc8130_provenance.
- NP500227.RAFWQb6KDbVC_yhPgcumMHbCL6__YH-Y3GLl7WVxDAqc8130_assertion wasGeneratedBy ECO_0000203 NP500227.RAFWQb6KDbVC_yhPgcumMHbCL6__YH-Y3GLl7WVxDAqc8130_provenance.